In addition, HADS scores were negatively correlated with ZFP36 expression and positively related with LRP5, β-catenin and NANOG expression in cohort 1 breast cancer patients (Supplementary Fig. 8k-n). This evidence concerns the gene ZFP36 and breast cancer.